Company registration number 10146964 (England and Wales)
RELIANCE CYBER SCIENCE LIMITED
FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
RELIANCE CYBER SCIENCE LIMITED
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 6
RELIANCE CYBER SCIENCE LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
31 December 2025
30 June 2024
Notes
£
£
£
£
Non-current assets
Investments
4
8,186,282
8,186,282
Current assets
Trade and other receivables
5
17,679,640
17,029,640
Cash and cash equivalents
8,273
40,086
17,687,913
17,069,726
Current liabilities
6
(650,001)
(9,501)
Net current assets
17,037,912
17,060,225
Total assets less current liabilities
25,224,194
25,246,507
Non-current liabilities
7
(28,000,000)
(28,000,000)
Net liabilities
(2,775,806)
(2,753,493)
Equity
Called up share capital
101
101
Share premium account
1,794,999
1,794,999
Retained earnings
(4,570,906)
(4,548,593)
Total equity
(2,775,806)
(2,753,493)
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the income statement within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 12 May 2026 and are signed on its behalf by:
A Rae
Director
Company registration number 10146964 (England and Wales)
RELIANCE CYBER SCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2025
- 2 -
1
Accounting policies
Company information
Reliance Cyber Science Limited is a private company limited by shares, incorporated in England and Wales. The registered office is 19-21 Catherine Place, London, SW1E 6DX.
1.1
Reporting period
The financial statements are prepared for a period of longer than one year in order to align with group companies. Therefore the comparative figures presented may not be directly comparable.
1.2
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
The company has taken advantage of the exemption under section 399 of the Companies Act 2006 not to prepare consolidated accounts, on the basis that the group of which this is the parent qualifies as a small group. The financial statements present information about the company as an individual entity and not about its group.
1.3
Going concern
The financial statements have been prepared on a going concern basis, which assumes that the company will continue in operational existence, and will be able to meet its liabilities as they fall due, for a period of at least twelve months from the date of approval of the financial statements.true
In concluding that it is appropriate to adopt the going concern basis in preparing the financial statements, the directors have had regard to the future growth plans for the company and the support received from its controlling parties, in ensuring funding is provided through its investment arms, to finance those plans. This is provided to finance the future growth plans for the family investment company.
Should the assumptions referred to in the directors’ assessment of the going concern basis above, prove to be invalid, the going concern basis may also be invalid and accordingly, adjustments may have to be made to reduce the value of the assets to their realisable amounts, to provide for any further liabilities which might arise and to reclassify all their fixed assets and long term liabilities as current assets and liabilities respectively.
1.4
Non-current investments
Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
RELIANCE CYBER SCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 3 -
1.5
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include other receivables and cash as bank balances, are measured at transaction price including transaction costs. Financial assets classified as receivable within one year are not amortised.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including loans from fellow group companies, are recognised at transaction price. Financial liabilities classified as payable within one year are not amortised.
Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities.
1.6
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of direct issue costs.
1.7
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
RELIANCE CYBER SCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.8
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense, when the company is demonstrably committed to terminate the employment of an employee, or to provide termination benefits.
1.9
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
Critical judgements
The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.
Investment impairment assessment
The value of investment in subsidiary has been assessed by the management at the year-end to determine if any impairment is required. Considering the financial projections of the subsidiary and valuations of similar businesses in the field, a decision has been taken not to provide for any impairment losses.
Amounts owed by group undertaking
The loan balance made to the group company is categorised as a short-term debtor, given the absence of a formal agreement. However, it is important to note that the balance is recoverable upon the sale of the group company. As a result, the group company does not have an immediate obligation to repay the loan.
RELIANCE CYBER SCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2025
- 5 -
3
Employees
The average monthly number of persons (including directors) employed by the company during the period was:
2025
2024
Number
Number
Total
3
3
4
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
8,186,282
8,186,282
5
Trade and other receivables
2025
2024
Amounts falling due within one year:
£
£
Amounts owed by group undertakings
17,679,640
17,029,640
6
Current liabilities
2025
2024
£
£
Other payables
650,001
9,501
7
Non-current liabilities
2025
2024
£
£
Other payables
28,000,000
28,000,000
On 15 March 2024 the company capitalised debt of £28,000,000 into 28,000,000 £1 fully paid, redeemable preference shares, included in other payables above.
The preference shares are redeemable at the option of the holder, hold no voting right and have a coupon rate of 0.001%.
8
Audit report information
As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.
The auditor's report is unqualified and includes the following:
RELIANCE CYBER SCIENCE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 31 DECEMBER 2025
8
Audit report information
(Continued)
- 6 -
Opinion
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its loss for the period then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
Senior Statutory Auditor:
Christopher Mantel
Statutory Auditor:
Alliotts LLP
Date of audit report:
12 May 2026
9
Related party transactions
Transactions with related parties
During the period the company entered into the following transactions with related parties:
The following amounts were outstanding at the reporting end date:
2025
2024
Amounts due to related parties
£
£
Other related parties
650,001
1
The following amounts were outstanding at the reporting end date:
2025
2024
Amounts due from related parties
£
£
Entities over which the entity has control, joint control or significant influence
17,679,640
17,029,640
Other information
The company has taken advantage of the exemption available in Paragraph 33.1A of FRS102 whereby it has not disclosed transactions with other companies that are wholly owned within the Group.
The balances due are unsecured, interest-free and repayable on demand.
10
Parent company
Until 23 July 2024 the ultimate parent undertaking was Cyber Sense Limited, a company incorporated in Jersey.
On 23 July 2024, these shares were transferred to two family trusts. As a result, Reliance Cyber Science Limited became the parent of the group.
The ultimate controlling parties are B Kingham and A Rae as trustees of the controlling trusts.